Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Lofexidine Men	35
Overall Study	STARTED	Lofexidine Women	24
Overall Study	STARTED	Placebo Men	24
Overall Study	STARTED	Placebo Women	29
Overall Study	COMPLETED	Lofexidine Men	30
Overall Study	COMPLETED	Lofexidine Women	18
Overall Study	COMPLETED	Placebo Men	23
Overall Study	COMPLETED	Placebo Women	25
Overall Study	NOT COMPLETED	Lofexidine Men	5
Overall Study	NOT COMPLETED	Lofexidine Women	6
Overall Study	NOT COMPLETED	Placebo Men	1
Overall Study	NOT COMPLETED	Placebo Women	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03718065/flow